HYLA Blood Sensor FDA Submission Aims for Clearance in 2024
Inspira Technologies has announced an advancement in its sensor technology with its HYLA Blood Sensor, which has achieved 95% accuracy.
Read MorePosted by Chris Wolski | Dec 26, 2023 | Blood Gas Analyzers |
Inspira Technologies has announced an advancement in its sensor technology with its HYLA Blood Sensor, which has achieved 95% accuracy.
Read MorePosted by Andy Lundin | Dec 7, 2023 | Hematology Instrumentation |
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Andy Lundin | Dec 4, 2023 | Lab Automation, Unknown Origin & Other Cancer Types |
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read MorePosted by Andy Lundin | Nov 17, 2023 | Transfusion & Transplantation Tests |
Verici Dx signed a licensing agreement with Thermo Fisher on an assay for pre-transplant prognostic testing of early kidney rejection risks.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read More